- Report
- February 2023
- 120 Pages
Israel
From €2164EUR$2,490USD£1,886GBP
- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2164EUR$2,490USD£1,886GBP
- Report
- January 2025
- 132 Pages
Global
From €3475EUR$3,999USD£3,029GBP
- Report
- July 2025
- 200 Pages
Japan
From €2164EUR$2,490USD£1,886GBP
- Report
- September 2020
- 168 Pages
Netherlands
From €1729EUR$1,990USD£1,507GBP
- Report
- July 2024
- 150 Pages
Global
From €5170EUR$5,950USD£4,507GBP
- Report
- June 2024
- 150 Pages
Global
From €5170EUR$5,950USD£4,507GBP
- Report
- February 2024
- 137 Pages
Global
From €4301EUR$4,950USD£3,750GBP
- Report
- March 2024
- 200 Pages
Global
From €3606EUR$4,150USD£3,144GBP
- Report
- August 2023
- 145 Pages
Global
From €2737EUR$3,150USD£2,386GBP
- Report
- October 2024
- 200 Pages
Global
From €3259EUR$3,750USD£2,841GBP
- Report
- May 2024
- 200 Pages
Global
From €3606EUR$4,150USD£3,144GBP
- Report
- March 2024
- 200 Pages
Global
From €3606EUR$4,150USD£3,144GBP
- Report
- February 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,401GBP
- Report
- January 2025
- 175 Pages
Global
From €3902EUR$4,490USD£3,401GBP
- Report
- January 2025
- 175 Pages
Global
From €3902EUR$4,490USD£3,401GBP
- Report
- January 2025
- 175 Pages
Global
From €3902EUR$4,490USD£3,401GBP
- Report
- January 2025
- 175 Pages
Global
From €3902EUR$4,490USD£3,401GBP
- Report
- March 2022
- 300 Pages
Global
From €4345EUR$5,000USD£3,788GBP
- Report
- December 2024
- 30 Pages
Global
From €2824EUR$3,250USD£2,462GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more